86662 Federal Register / Vol. 88, No. 239 / Thursday, December 14, 2023 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the Advisory Committee on 

Interdisciplinary, Community-Based 

Linkages 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the Advisory 

Committee on Interdisciplinary, 

Community-Based Linkages (ACICBL) 

will hold public meetings for the 2024 

calendar year (CY). Information about 

ACICBL, agendas, and materials for 

these meetings can be found on the 

ACICBL website at https://

www.hrsa.gov/advisory-committees/ 

interdisciplinary-community-linkages. 

DATES: ACICBL meetings will be held on 

• January 25, 2024, 8:00 a.m.–5:00 p.m. 

Eastern Time (ET) and January 26, 

2024, 8 a.m.–4 p.m. ET 

• April 19, 2024, 10 a.m.–5 p.m. ET 

• September 6, 2024, 10 a.m.–5 p.m. ET 

ADDRESSES: Meetings may be held in 

person, by teleconference, and/or Zoom. 

For updates on how the meetings will 

be held, visit the ACICBL website 30 

business days before the date of the 

meeting, where instructions for joining 

meetings will be posted. In-person 

ACICBL meetings will be held at 5600 

Fishers Lane, Rockville, Maryland 

20857. For meeting information 

updates, go to the ACICBL website 

meeting page at https://www.hrsa.gov/ 

advisory-committees/interdisciplinarycommunity-linkages/meetings. 

FOR FURTHER INFORMATION CONTACT: 

Shane Rogers, Designated Federal 

Officer, Division of Medicine and 

Dentistry, Bureau of Health Workforce, 

HRSA, 5600 Fishers Lane, Room 

15N142, Rockville, Maryland 20857; 

301–443–5260; or SRogers@hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACICBL 

provides advice and recommendations 

to the Secretary of HHS on policy, 

program development, and other 

matters of significance concerning the 

activities authorized under sections 

750–760, Title VII, Part D of the Public 

Health Service Act. ACICBL submits an 

annual report to the Secretary of HHS 

and to Congress describing its activities, 

including findings and 

recommendations made by ACICBL 

concerning the activities under sections 

750–760 of the Public Health Service 

Act. In addition, ACICBL develops, 

publishes, and implements performance 

measures and guidelines for 

longitudinal evaluations, as well as 

recommends appropriation levels for 

programs under Part D of Title VII. 

Since priorities dictate meeting times, 

be advised that start times, end times, 

and agenda items are subject to change. 

For CY 2024 meetings, agenda items 

may include, but are not limited to, 

policy and program development and 

other significant matters related to 

activities authorized under Part D of the 

Public Health Service Act, positioning 

the public health system to anticipate 

future needs, reversing the negative 

trend in health care recruitment and 

retention, and identifying ways for 

incentivizing for health equity. Refer to 

the ACICBL website listed above for all 

current and updated information 

concerning CY 2024 ACICBL meetings, 

including agendas and meeting 

materials that will be posted 30 calendar 

days before the meeting. 

Members of the public will have the 

opportunity to provide comments. 

Public participants may submit written 

statements in advance of the scheduled 

meeting(s). Oral comments will be 

honored in the order they are requested 

and may be limited as time allows. 

Requests to submit a written statement 

or make oral comments to ACICBL 

should be sent to Shane Rogers using 

the contact information above at least 5 

business days before the meeting 

date(s). 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Shane 

Rogers using the contact information 

listed above at least 10 business days 

before the meeting(s) they wish to 

attend. Since all in person meetings will 

occur in a federal government building, 

attendees must go through a security 

check to enter the building. Non-U.S. 

Citizen attendees must notify HRSA of 

their planned attendance at least 20 

business days prior to the meeting in 

order to facilitate their entry into the 

building. All attendees are required to 

present government-issued 

identification prior to entry. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–27499 Filed 12–13–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Alzheimer’s 

Disease Drug Development. 

Date: January 18, 2024. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

RM: 2E400, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Mariel Jais, Ph.D., M.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institutes of Health, 

National Institute on Aging, 7201 Wisconsin 

Avenue, RM: 2E400, Bethesda, MD 20892, 

(301) 594–2614, mariel.jais@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 8, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–27424 Filed 12–13–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 239 / Thursday, December 14, 2023 / Notices 86663 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topic: Pain Therapeutics. 

Date: January 5, 2024. 

Time: 12:00 p.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lai Yee Leung, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1011D, 

Bethesda, MD 20892, (301) 827–8106, 

leungl2@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 8, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–27421 Filed 12–13–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; NIGMS Review of Applications for 

Innovative Programs to Enhance Research 

Training (IPERT) (R25), MOSAIC (UE5), and 

Conference (R13) Applications. 

Date: March 6–7, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute of General Medical 

Sciences, Natcher Building, 45 Center Drive, 

Bethesda, Maryland 20892 (Virtual Meeting). 

Contact Person: Latarsha J. Carithers, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, 45 Center Drive, Room 3AN12C, 

Bethesda, Maryland 20892, 301–594–4859, 

latarsha.carithers@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: December 8, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–27422 Filed 12–13–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Career 

Development Facilitating The Transition to 

Independence Study Section. 

Date: February 15–16, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue 

RM: 2W200, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: Joshua Park, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institutes of Health, 

National Institute on Aging, 7201 Wisconsin 

Avenue RM: 2W200, Bethesda, MD 20892, 

(301) 496–6208, joshua.park4@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 8, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–27423 Filed 12–13–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Neurological Sciences 

Training Initial Review Group; NST–1 Study 

Section. 

Date: January 29–30, 2024. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: William C. Benzing, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Blvd., 

Rockville, MD 20892, 301–496–0660, 

benzingw@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS.) 

Dated: December 8, 2023. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–27448 Filed 12–13–23; 8:45 am] 

BILLING CODE 4140–01–P 


lotter on DSK11XQN23PROD with NOTICES1